PDGFRα, PDGFRβ and KIT expression/activation in conventional chondrosarcoma
- 7 February 2006
- journal article
- research article
- Published by Wiley in The Journal of Pathology
- Vol. 208 (5) , 615-623
- https://doi.org/10.1002/path.1945
Abstract
No abstract availableKeywords
This publication has 28 references indexed in Scilit:
- cDNA expression profiling of chondrosarcomas: Ollier disease resembles solitary tumours and alteration in genes coding for components of energy metabolism occurs with increasing gradeThe Journal of Pathology, 2005
- 9p21 locus analysis in high-risk gastrointestinal stromal tumors characterized forc-kit and platelet-derived growth factor receptor α gene alterationsCancer, 2005
- Tyrosine Phosphorylation and Endothelial Cell Barrier RegulationThe American Journal of Pathology, 2005
- Chemosensitization by STI571 targeting the platelet‐derived growth factor/platelet‐derived growth factor receptor‐signaling pathway in the tumor progression and angiogenesis of gastric carcinomaCancer, 2005
- Absence of IHH and retention of PTHrP signalling in enchondromas and central chondrosarcomasThe Journal of Pathology, 2005
- Detection of Overexpressed and Phosphorylated Wild-Type Kit Receptor in Surgical Specimens of Small Cell Lung CancerClinical Cancer Research, 2004
- Expression of Ligand-Activated KIT and Platelet-Derived Growth Factor Receptor β Tyrosine Kinase Receptors in Synovial SarcomaClinical Cancer Research, 2004
- Grade 2 Chondrosarcoma: Stage I or Stage II Tumor?Clinical Orthopaedics and Related Research, 2003
- Platelet-Derived Growth Factor-α Receptor Expression Supports the Growth of Conventional Chondrosarcoma and Is Associated With Adverse OutcomeThe American Journal of Surgical Pathology, 2001
- Evidence for Distinct Signaling Properties and Biological Responses Induced by the PDGF Receptor α and β SubtypesGrowth Factors, 1999